SEC Expands Pfizer Bribery Inquiries Into China
Pfizer Inc. is cooperating with the U.S. Securities and Exchange Commission following a bribery-related inquiry into the drugmaking giant's China operations, according to the company's third-quarter financial statements....To view the full article, register now.
Already a subscriber? Click here to view full article